1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC153W |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Tumor Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 °C, 5% CO2 |
Source Organ | Ovarian mucinous carcinoma tissues |
Disease | Ovarian Mucinous Carcinoma |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Ovarian Mucinous Carcinoma Tumor Cells |
Human Ovarian Mucinous Carcinoma Tumor Cells are derived from human ovarian mucinous carcinoma tissues, providing a robust platform for studying ovarian cancer biology, progression, and therapeutic strategies. These cells exhibit key pathological features, including mucin secretion, aggressive growth behavior, resistance to apoptosis, and chemotherapeutic resistance mechanisms, closely resembling the clinical manifestations of ovarian mucinous carcinoma. Frequently employed to investigate oncogenic pathways, such as EGFR signaling, mucin-related glycoproteins expression, and epithelial-mesenchymal transition (EMT), these cells facilitate discovery of targeted therapeutics and biomarkers. They serve as valuable models for drug screening, mechanistic research, and personalized oncology.
For research use only.
Human Ovarian Mucinous Carcinoma Tumor Cells are widely utilized in ovarian cancer research to study tumor proliferation, metastatic potential, and drug resistance. They are essential tools for evaluating chemotherapeutic efficacy, exploring mucin biology, and identifying novel molecular targets. Additionally, these cells aid in the development of personalized treatments and biomarker-driven therapeutic strategies.